Intercytex reports on Phase I trial of replacement skin product

Intercytex Group Plc announced on 26 June, 2007 that its replacement for skin grafts was successful in a Phase I trial, representing the first time that laboratory-made, living human skin has been fully and consistently integrated into the human body.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom